🔗 Visit the ClinicalTrials.gov page for NCT01516203
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Advances in the development of new tuberculosis drugs and treatment regimens. | Nat Rev Drug Discov | 2013 | 3.50 |
| 2 | TB and HIV Therapeutics: Pharmacology Research Priorities. | AIDS Res Treat | 2012 | 0.94 |
| 3 | Recent advances in tuberculosis: New drugs and treatment regimens. | Curr Respir Med Rev | 2013 | 0.91 |
| 4 | New agents for the treatment of drug-resistant Mycobacterium tuberculosis. | Adv Drug Deliv Rev | 2016 | 0.90 |
| 5 | Early Bactericidal Activity of AZD5847 in Pulmonary Tuberculosis. | Antimicrob Agents Chemother | 2016 | 0.86 |
| 6 | Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations? | Korean J Intern Med | 2015 | 0.78 |
| 7 | Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis. | Antimicrob Agents Chemother | 2015 | 0.75 |
| 8 | Pipeline of Known Chemical Classes of Antibiotics. | Antibiotics (Basel) | 2013 | 0.75 |